Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Hanish Jain, Garima Singh, Viren Kaul & Harvir Singh Gambhir. (2022) Management dilemmas in restarting anticoagulation after gastrointestinal bleeding. Baylor University Medical Center Proceedings 35:3, pages 322-327.
Read now
Read now
Monika Kozieł, Wern Yew Ding, Zbigniew Kalarus & Gregory Y. H. Lip. (2019) Considerations when restarting anticoagulants in patients with atrial fibrillation after bleeding. Expert Review of Hematology 12:10, pages 845-855.
Read now
Read now
Articles from other publishers (23)
Mohammad Rizki Akbar, Mega Febrianora & Mohammad Iqbal. (2023) Warfarin Usage in Patients With Atrial Fibrillation Undergoing Hemodialysis in Indonesian Population. Current Problems in Cardiology 48:5, pages 101104.
Crossref
Crossref
Maria Stefil, Katarzyna Nabrdalik & Gregory Y.H. Lip. (2021) Renal Disease and Atrial Fibrillation. Cardiac Electrophysiology Clinics 13:1, pages 95-112.
Crossref
Crossref
Salman Hussain, Ali Nasir Siddiqui, Harveen Baxi, Anwar Habib, Md Sarfaraj Hussain & Abul Kalam Najmi. (2019) Warfarin use increases bleeding risk in hemodialysis patients with atrial fibrillation: A meta‐analysis of cohort studies. Journal of Gastroenterology and Hepatology 34:6, pages 975-984.
Crossref
Crossref
Jingwen Tan, Sunjae Bae, Jodi B Segal, Junya Zhu, G Caleb Alexander, Dorry L Segev & Mara McAdams-DeMarco. (2019) Warfarin use and the risk of stroke, bleeding, and mortality in older adults on dialysis with incident atrial fibrillation. Nephrology 24:2, pages 234-244.
Crossref
Crossref
Kathrine Parker, Sandip Mitra & Jecko Thachil. (2018) Is anticoagulating haemodialysis patients with non-valvular atrial fibrillation too risky?. British Journal of Haematology 181:6, pages 725-736.
Crossref
Crossref
R. Pisters, A. Elvan, H. J. G. M. Crijns & M. E. W. Hemels. (2018) Optimal long-term antithrombotic management of atrial fibrillation: life cycle management. Netherlands Heart Journal 26:6, pages 311-320.
Crossref
Crossref
Tatjana S. Potpara, Charles J. Ferro & Gregory Y. H. Lip. (2018) Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction. Nature Reviews Nephrology 14:5, pages 337-351.
Crossref
Crossref
Aamer Ahmed, Sibylle Kozek-Langenecker, François Mullier, Sue Pavord & Cedric Hermans. (2018) European guidelines on perioperative venous thromboembolism prophylaxis. European Journal of Anaesthesiology 35:2, pages 96-107.
Crossref
Crossref
Kazuhiko Kido & Michael J. Scalese. (2017) Management of Oral Anticoagulation Therapy After Gastrointestinal Bleeding: Whether to, When to, and How to Restart an Anticoagulation Therapy. Annals of Pharmacotherapy 51:11, pages 1000-1007.
Crossref
Crossref
Chang-Yun YoonJuhwan NohJong Hyun JheeTae Ik ChangEa Wha KangYoun Kyung KeeHyoungnae KimSeohyun ParkHae-Ryong YunSu-Young JungHyung Jung OhJung Tak ParkSeung Hyeok HanShin-Wook KangChangsoo KimTae-Hyun Yoo. (2017) Warfarin Use in Patients With Atrial Fibrillation Undergoing Hemodialysis. Stroke 48:9, pages 2472-2479.
Crossref
Crossref
Christos Voukalis & Gregory Y.H. Lip. (2017) Atrial Fibrillation and End Stage Renal Failure in Patients Receiving Dialysis: Balancing the Risks and Benefits of Stroke Prevention. Canadian Journal of Cardiology 33:6, pages 705-707.
Crossref
Crossref
Ziv Harel, Glenn M. Chertow, Prakesh S. Shah, Shai Harel, Paul Dorian, Andrew T. Yan, Gustavo Saposnik, Manish M. Sood, Amber O. Molnar, Jeffrey Perl, Rachel M. Wald, Sam Silver & Ron Wald. (2017) Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis. Canadian Journal of Cardiology 33:6, pages 737-746.
Crossref
Crossref
Pierre Delanaye, Antoine Bouquegneau, Bernard E. Dubois, Muriel Sprynger, Christophe Mariat, Jean-Marie Krzesinski & Patrizio Lancellotti. (2017) Fibrillation auriculaire et anticoagulation chez le patient hémodialysé : une décision difficile. Néphrologie & Thérapeutique 13:2, pages 59-66.
Crossref
Crossref
Hans Van Der Meersch, Dirk De Bacquer & An S. De Vriese. (2017) Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysis. American Heart Journal 184, pages 37-46.
Crossref
Crossref
Jingwen Tan, Shuiqing Liu, Jodi B. Segal, G. Caleb Alexander & Mara McAdams-DeMarco. (2016) Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis. BMC Nephrology 17:1.
Crossref
Crossref
Yee C. Lau, Marco Proietti, Elisa Guiducci, Andrew D. Blann & Gregory Y.H. Lip. (2016) Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease. Journal of the American College of Cardiology 68:13, pages 1452-1464.
Crossref
Crossref
Christopher X. Wong, Ayodele Odutayo, Connor A. Emdin, Ned J. Kinnear & Michelle T. Sun. (2016) Meta-Analysis of Anticoagulation Use, Stroke, Thromboembolism, Bleeding, and Mortality in Patients With Atrial Fibrillation on Dialysis. The American Journal of Cardiology 117:12, pages 1934-1941.
Crossref
Crossref
Meng Lee, Jeffrey L. Saver, Keun-Sik Hong, Yi-Ling Wu, Wen-Hong Huang, Neal M. Rao & Bruce Ovbiagele. (2016) Warfarin Use and Risk of Stroke in Patients With Atrial Fibrillation Undergoing Hemodialysis. Medicine 95:6, pages e2741.
Crossref
Crossref
Ying Bai, Hui Chen, Yi Yang, Li Li, Xin-Yao Liu, Xu-Bo Shi & Chang-Sheng Ma. (2016) Safety of antithrombotic drugs in patients with atrial fibrillation and non-end-stage chronic kidney disease: Meta-analysis and systematic review. Thrombosis Research 137, pages 46-52.
Crossref
Crossref
Daniel M. Witt, Nathan P. Clark, Kerri Martinez, Allison Schroeder, David Garcia, Mark A. Crowther, Walter Ageno, Francesco Dentali, Xiangyang Ye, Elaine Hylek & Thomas Delate. (2015) Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage. Thrombosis Research 136:5, pages 1040-1044.
Crossref
Crossref
Mitesh Shah, Meytal Avgil Tsadok, Cynthia A. Jackevicius, Vidal Essebag, Mark J. Eisenberg, Elham Rahme, Karin H. Humphries, Jack V. Tu, Hassan Behlouli, Helen Guo & Louise Pilote. (2014) Response to Letter Regarding Article, “Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis”. Circulation 130:25.
Crossref
Crossref
Waqas Qureshi, Zaid Alirhayim & Fatima Khalid. (2014) Letter by Qureshi et al Regarding Article, “Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis”. Circulation 130:25.
Crossref
Crossref
Mona Hassan, Waqas Qureshi, Laila S Sroujieh, Derar Albashaireh, Sara BouMalham, Meghan Liroff, Waseem Amjad, Fatima Khalid, Hiba Hadid & Zaid Alirhayim. (2014) Interplay of parathyroid hormone and aldosterone antagonist in prevention of heart failure hospitalizations in chronic kidney disease. Journal of the Renin-Angiotensin-Aldosterone System 15:3, pages 278-285.
Crossref
Crossref